Get the Stockscreener App
10.20
5.05%
0.49
Kodiak Sciences Inc stock is traded at $10.20, with a volume of 669.89K.
It is up +5.05% in the last 24 hours and up +82.80% over the past month.
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
See More
Previous Close:
$9.71
Open:
$9.83
24h Volume:
669.89K
Relative Volume:
1.40
Market Cap:
$538.78M
Revenue:
-
Net Income/Loss:
$-197.68M
P/E Ratio:
-2.7128
EPS:
-3.76
Net Cash Flow:
$-158.88M
1W Performance:
-3.50%
1M Performance:
+82.80%
6M Performance:
+129.21%
1Y Performance:
+280.60%
1-Day Range:
$9.62
$10.39
1-Week Range:
$8.77
$11.29
52-Week Range:
$1.92
$11.60
Kodiak Sciences Inc Stock (KOD) Company Profile
Name
Kodiak Sciences Inc
Sector
Industry
Phone
650-281-0850
Address
1200 PAGE MILL RD, PALO ALTO, CA
Compare KOD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KOD
Kodiak Sciences Inc
|
10.20 | 594.24M | 0 | -197.68M | -158.88M | -3.76 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-14-25 | Upgrade | JP Morgan | Underweight → Neutral |
| Dec-09-24 | Upgrade | Jefferies | Hold → Buy |
| Sep-05-24 | Initiated | H.C. Wainwright | Neutral |
| Dec-11-23 | Resumed | Goldman | Sell |
| Nov-17-23 | Upgrade | CapitalOne | Equal Weight → Overweight |
| Jul-27-23 | Downgrade | UBS | Buy → Neutral |
| Jul-25-23 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jul-25-23 | Downgrade | JP Morgan | Neutral → Underweight |
| Jul-24-23 | Downgrade | CapitalOne | Overweight → Equal Weight |
| Jul-24-23 | Downgrade | Jefferies | Buy → Hold |
| Nov-15-22 | Initiated | CapitalOne | Overweight |
| Aug-02-22 | Downgrade | Citigroup | Neutral → Sell |
| Feb-24-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-02-22 | Upgrade | JP Morgan | Neutral → Overweight |
| May-11-21 | Upgrade | ROTH Capital | Neutral → Buy |
| Mar-12-21 | Initiated | Evercore ISI | Outperform |
| Mar-01-21 | Downgrade | Barclays | Equal Weight → Underweight |
| Feb-17-21 | Downgrade | ROTH Capital | Buy → Neutral |
| Jan-25-21 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Dec-17-20 | Initiated | Berenberg | Buy |
| Dec-16-20 | Initiated | UBS | Buy |
| Dec-11-20 | Initiated | Citigroup | Neutral |
| Nov-30-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-16-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-13-20 | Downgrade | Goldman | Buy → Neutral |
| Mar-31-20 | Initiated | BMO Capital Markets | Outperform |
| Mar-03-20 | Initiated | Goldman | Buy |
| Feb-18-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-06-20 | Initiated | SunTrust | Buy |
| Jan-08-20 | Initiated | ROTH Capital | Buy |
| Jan-03-20 | Initiated | Jefferies | Buy |
| Dec-24-19 | Initiated | JP Morgan | Overweight |
| Oct-15-19 | Reiterated | Chardan Capital Markets | Buy |
| Feb-20-19 | Initiated | Chardan Capital Markets | Buy |
| Oct-29-18 | Initiated | Barclays | Overweight |
| Oct-29-18 | Initiated | BofA/Merrill | Buy |
| Oct-29-18 | Initiated | Morgan Stanley | Overweight |
View All
Kodiak Sciences Inc Stock (KOD) Latest News
Kodiak Sciences Inc.'s (NASDAQ:KOD) high institutional ownership speaks for itself as stock continues to impress, up 11% over last week - Yahoo Finance
Volatility clustering patterns for Kodiak Sciences Inc.2025 Momentum Check & High Accuracy Swing Trade Signals - Newser
Risk vs reward if holding onto Kodiak Sciences Inc.Market Trend Report & Capital Efficiency Focused Strategies - Newser
Using R and stats models for Kodiak Sciences Inc. forecastingBond Market & Real-Time Stock Entry Alerts - Newser
Price action breakdown for Kodiak Sciences Inc.2025 Retail Activity & Real-Time Volume Analysis - Newser
Long term hold vs stop loss in Kodiak Sciences Inc.2025 Trade Ideas & Stepwise Trade Signal Implementation - Newser
Volume spikes in Kodiak Sciences Inc. stock – what they meanAnalyst Downgrade & High Conviction Buy Zone Alerts - Newser
Trend analysis for Kodiak Sciences Inc. this weekMarket Movement Recap & AI Powered Market Entry Strategies - Newser
Can volume confirm reversal in Kodiak Sciences Inc.Analyst Upgrade & Daily Oversold Stock Bounce Ideas - Newser
How to integrate Kodiak Sciences Inc. into portfolio analysis toolsJuly 2025 Sentiment & Fast Momentum Entry Tips - Newser
Technical signs of recovery in Kodiak Sciences Inc.Buy Signal & Breakout Confirmation Trade Signals - Newser
Kodiak Sciences to Present at American Chemical Society Fall 2025 - MarketScreener
What does recent volatility data suggest for Kodiak Sciences Inc.Weekly Trend Recap & Short-Term Swing Trade Alerts - Newser
How to recover losses in Kodiak Sciences Inc. stock2025 Market WrapUp & Safe Capital Preservation Plans - Newser
What MACD and RSI say about Kodiak Sciences Inc.Trade Risk Report & Free High Return Stock Watch Alerts - Newser
Is Kodiak Sciences Inc. stock entering bullish territoryPortfolio Update Report & Free Risk Controlled Daily Trade Plans - Newser
Kodiak Sciences stock price target raised to $5 from $3 at H.C. Wainwright - Investing.com
Analysts Divided on Akero Therapeutics and Kodiak Sciences: AKRO and KOD Ratings Revealed - AInvest
Kodiak Sciences: HC Wainwright Raises PT to $5, Maintains Neutral Rating - AInvest
Key metrics from Kodiak Sciences Inc.’s quarterly dataMarket Growth Review & Free Technical Pattern Based Buy Signals - Newser
Is Kodiak Sciences Inc. stock forming a cup and handleCEO Change & Stepwise Entry/Exit Trade Alerts - classian.co.kr
Kodiak Sciences Beats Q2 Loss Estimates - AOL.com
Forecasting Kodiak Sciences Inc. price range with options data2025 Price Action Summary & Verified Momentum Stock Ideas - Newser
What high frequency data says about Kodiak Sciences Inc.Free AI Powered High Return Stock Calls - Newser
Will Kodiak Sciences Inc. stock benefit from interest rate changesGold Moves & AI Forecast Swing Trade Picks - Newser
Real time pattern detection on Kodiak Sciences Inc. stockBond Market & Smart Investment Allocation Insights - Newser
Why Kodiak Sciences Inc. stock attracts strong analyst attentionPortfolio Gains Report & High Return Trade Guides - thegnnews.com
Kodiak Sciences Q2 2025 Earnings: Net Loss Increases, Clinical Progress and Digital Health Initiatives Highlighted - AInvest
JP Morgan Upgrades Kodiak Sciences (KOD) to Neutral with New Price Target of $15.00 - AInvest
Barclays Raises Kodiak Sciences Price Target to $7.00, Maintains 'Underweight' Rating - AInvest
Kodiak Q2 Loss Wider Than Expected, Pipeline Development in Focus - MSN
XTX Topco Ltd Acquires New Stake in Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World
How to build a custom watchlist for Kodiak Sciences Inc.2025 Key Lessons & Weekly Top Gainers Trade List - Newser
Kodiak Sciences (KOD) up more than 100% since Jul 22 - AInvest
Kodiak Q2 Loss Wider Than Expected, Pipeline Development In Focus - Barchart.com
Kodiak Sciences Inc Stock (KOD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):